# | Name | Compound Key | Action Type | Relation | Activity Value | Units | Assay ID | Assay Description | Comment | Assay | Assay Organism | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | ALA455372 | 8 | MIC | = | 0.78 | ug ml-1 | ALA5261185 | ug.mL-1 | Streptococcus agalactiae | |||
2. | ALA455372 | 8 | IC50 | = | 2.9 | ug ml-1 | ALA5261170 | ug.mL-1 | Homo sapiens | |||
3. | ALA455372 | 8 | IC50 | = | 5.1 | ug ml-1 | ALA5261169 | ug.mL-1 | Homo sapiens | |||
4. | ALA455372 | 8 | IC50 | = | 50 | ug ml-1 | ALA5261168 | ug.mL-1 | Mycobacterium tuberculosis | |||
5. | ALA455372 | 8 | IC50 | = | 5.5 | ug ml-1 | ALA5261167 | ug.mL-1 | Plasmodium falciparum | |||
6. | ALA455372 | 8 | Activity | 0 | ALA5255946 | Dose-Dependent Effect | ||||||
7. | ALA455372 | 8 | GI50 | > | 100 | uM | ALA5255945 | nM | Homo sapiens | |||
8. | ALA455372 | 8 | GI50 | = | 2.57 | uM | ALA5255944 | nM | ||||
9. | ALA455372 | 8 | INH | 0 | ALA1838287 | Dose-dependent effect | % | Clostridium perfringens | ||||
10. | ALA455372 | 8 | IC50 | = | 3.35 | uM | ALA1838287 | 5.47 | nM | Clostridium perfringens | ||
11. | ALA455372 | 8 | Ki | = | 2.73 | uM | ALA1838286 | 5.56 | nM | Clostridium perfringens | ||
12. | ALA455372 | 8 | IC50 | > | 30 | uM | ALA1101508 | nM | Homo sapiens | |||
13. | ALA455372 | 8 | IC50 | > | 30 | uM | ALA1101507 | nM | Homo sapiens | |||
14. | ALA455372 | 8 | IC50 | > | 30 | uM | ALA1101506 | nM | Homo sapiens | |||
15. | ALA455372 | 8 | IC50 | > | 30 | uM | ALA1101505 | nM | Homo sapiens | |||
16. | ALA455372 | 8 | IC50 | > | 30 | uM | ALA1101504 | nM | Homo sapiens | |||
17. | ALA455372 | 8 | Activity | 0 | ALA1026202 | Non-toxic | ||||||
18. | ALA455372 | 8 | IC50 | = | 5.5 | uM | ALA1026201 | 5.26 | nM | |||
19. | ALA455372 | 8 | Activity | 0 | ALA1063051 | Non-toxic | ||||||
20. | ALA455372 | 8 | IC50 | = | 2 | uM | ALA1063050 | 5.70 | nM |